Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $27.58 is 64.17% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 27.745||$ 37.23|
|Low:||$ 26.27||$ 16.80|
Company Description (as filed with the SEC)
We are a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of rare genetic deficiencies that result in lifethreatening metabolic disorders. Our lead peptide product candidate is setmelanotide, a potent, firstinclass melanocortin4 receptor, or MC4R, agonist for the treatment of rare genetic disorders of obesity. We believe setmelanotide, for which we have exclusive worldwide rights, has the potential to serve as replacement therapy for the treatment of melanocortin4, or MC4, pathway deficiencies. MC4 pathway deficiencies result in the disruption of satiety signals and energy homeostasis in the body, which, in turn, leads to intense feelings of hunger and to obesity. ... More ...
Nasdaq Official Price
Dec. 10, 2018
Dec. 10, 2018